ABSTRACT
Importance The Coronavirus Disease 2019 (COVID-19) pandemic has had wide-spread impacts on health and behavioral patterns. Returning university students represent large-scale, transient demographic shifts and a potential source of transmission risk to adjacent communities.
Objective Test the a priori hypothesis that the Fall 2020 student return-to-campus would correlate with an increase in infection rates in the surrounding community; identify risk factors for SARS-CoV-2 infection within and between the subgroups.
Design Prospective longitudinal cohort study.
Setting Conducted in Centre County, Pennsylvania, USA from August 2020 to December 2020.
Participants Non-random cohorts of county residents 18 years of age or older living in Centre County prior to the return to in-person instruction at the Pennsylvania State University and returning students who were enrolled during the Fall 2020 term.
Exposure(s) Contact with known SARS-CoV-2-positive and COVID-symptomatic individuals, attending gatherings of various sizes, and adherence to public health non-pharmaceutical interventions.
Main Outcome(s) and Measure(s) Presence of IgG antibodies against the SARS-CoV-2 surface spike glycoprotein (S) receptor-binding domain (S/RBD), measured using an indirect isotype-specific (IgG) screening enzyme immunoassay.
Results Of 345 community participants, 19 (5.5%) were positive for SARS-CoV-2 IgG antibodies at their first visit between 7 August and 2 October. Of 625 returning student participants, 195 (31.2%) were positive for SARS-CoV-2 antibodies between 26 October and 23 November. 28 (8.1%) of the community participants had returned a positive result by 9 December. Only contact with known SARS-CoV-2-positive individuals and attendance at small gatherings (20-50 individuals) were significant predictors of IgG antibodies among returning students (aOR, 95% CI: 3.24, 2.14-4.91, p<0.001; 1.62, 1.08-2.44, p<0.05; respectively).
Conclusions and Relevance Despite high seroprevalence observed within the student population, seroprevalence in a longitudinal cohort of community residents was low and stable from before student arrival for the Fall 2020 term to after student departure, implying limited transmission between these cohorts. This implies the potential to minimize the transmission of SARS-CoV-2 from high prevalence, geographically coincident sub-populations. Future work should investigate the relative efficacy of specific measures to reduce risk of transmission from itinerant to resident populations and guide communities with high levels of episodic migration and similar social configurations.
Question What was the effect of a large population influx on SARS-CoV-2 seroprevalence in an immunologically naïve resident population?
Findings Despite high seroprevalence observed within the student population, seroprevalence in a longitudinal cohort of community residents remained low and stable from before student arrival for the Fall term to after their departure, implying limited transmission between these subpopulations. Contact with an individual known to be SARS-CoV-2 positive and attending small gatherings were the only significant risk factors among returning students.
Meaning The demographic shift associated with student return to campus was not associated with increased SARS-CoV-2 seroprevalence in this cohort of community residents.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.protocols.io/view/quantitative-estimation-of-igm-and-igg-antibodies-bivgke3w
Funding Statement
This research was supported by funding from the Office of the Provost and the Clinical and Translational Science Institute, Huck Life Sciences Institute, and Social Science Research Institutes at the Pennsylvania State University. The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding sources had no role in the collection, analysis, interpretation, or writing of the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This human subjects research was conducted with PSU Institutional Review Board approval (study number: STUDY00015547) and in accordance with the Declaration of Helsinki.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Edited for language and updated formatting/word count for JAMA Open submission
Data Availability
At present, data is deemed to contain personal health information (PHI) so cannot be shared as per the IRB approval. However, at a later date, a clean dataset without PHI will be added to a public GitHub repository, and the submission information will be updated to include the appropriate links to the data and analysis files.
